Low Level Laser Therapy by Greatcore

Introduction to Low Level Laser Therapy (LLLT)

Low level laser therapy has been used widely in Canada, Europe and Asia for over 30 years to treat various rheumatological, neurologic, chiropractic, dental and dermatologic disorders. In recent times, there has been increasing awareness and acceptance of LLLT amongst doctors around the world as more venture into trying proven alternative therapies. Moreover, LLLT is non-invasive, safe and uses scientifically proven technology.

There are more than 3500 published scientific papers on the “biomodulation” benefits of LLLT. The aim of biomodulation is to stimulate the cells to function optimally within the target range. Through photonic absorption, laser light energy converts into chemical energy which initiates a cascade of chemical reactions at a cellular level.

How does it work at the cellular level? Photonic energy is absorbed by the photo-acceptor sites on the cell membrane which trigger a secondary messenger to initiate a cascade of intracellular signals that initiate, inhibit or accelerate biological processes such as wound healing, reducing inflammation and pain management.

* LLLT promotes healing when it penetrates the skin, increases ATP and activates enzymes in the targeted cells.
* Increased ATP and protein synthesis increases growth factor response in the cells and more energy leads to optimal cellular functioning
* It improves cell proliferation
* Strengthens the immune system response by increasing levels of lymphocyte activity
* Pain relief resulting from endorphin release

Intravascular low level laser therapy first began in Russia and was introduced into China in 1990. To date, in China alone, the intravascular irradiation of low power laser has been used to treat various pathological processes – including neurological, heart, urinary, respiratory, dermal, gynecological, eye and ear, nose throat diseases in 10,000 patients. In this technique, low intensity laser is guided by an optical fibre needle through an intravenous catheter into a blood vessel to irradiate circulating blood.

There are several drawbacks with this technique.

1. It's invasive - giving rise to risk of infection
2. It's painful - many people are needle-phobic
3. It’s has to be performed by trained medical personnel in a clinic or hospital.

This leads us to develop RadiantLife LT.

The Greatcore/RadiantLife LT Low Level Laser Technology

RadiantLife LT is designed to overcome the problems of intravascular LLLT. It is developed by Greatcore and built in Malaysia, giving you the best in technology and manufacturing cost and capability. Quality is assured in our ISO9000 certified manufacturing facility. The product is designed with the customer first in mind, and as a result, we have a robust product with a simplistic form that is easy and convenient to use. Particular attention was given to the design of the circuit such that power is regulated and delivered at maximum efficiency, which requires only one 1.5 V AA alkaline battery for 60 hours of operation. Based on recommended usage of two 25 minutes session daily, one battery will last for 2 months! This product is CE certified to EC directives EN 60601-1: 1990 + A1 + A2 (Medical Device Directive).

RadiantLife LT is a compact, portable, electronic home-use device that uses laser light energy to enhance your general well-being. It is safe, efficacious, non-drug, non-invasive, and uses scientifically proven technology.

An applicator is inserted into the nose where a small dose of low intensity laser light of 655 nm wavelength is applied to the blood vessels. The nose is one of few available areas in the human body where blood capillaries are in abundance close to the surface of the skin. In just 25 minutes of use, the red blood cells can be seen under a microscope, to have significantly less clumping, and with better form. These are indicators of improved circulation, and more efficient oxygen and mineral transport capability.

Many published scientific studies on the "biomodulation" benefits of LLLT that are relevant to RadiantLife LT have been done to prove the following benefits;

* Decreases blood viscosity, improves circulation and improves red blood cell deformability 2
* Strengthens the immune system 3,4,5
* Improves peripheral circulation in medical conditions like diabetes 6,7
* Lowers blood pressure 8

Other uses of low level laser treatment include, aiding in the management of;

* High blood lipids 15,16
* Coronary heart diseases 10,11,12
* Neural diseases 13
* Renal diseases 14
* Allergic rhinitis 9
* Headache & Migraine 17

References:

1. Cicha I, et al. "Effects of dietary triglycerides on rheological properties of human red blood cells". Clin Hemorrheol Microcirc. 2004; 30 (3-4): 301-5

2. Mi XQ, et al. "In vitro effect of helium-neon laser irradiation on human blood: blood viscosity and deformability of erythrocytes". Photomed Laser Surg. 2004; 22(6): 477-82

3. Gulsoy M, et al. "The biological effects of 632.8 nm low energy He-Ne laser on peripheral blood mononuclear cells in vitro". J Photochem Photobiol B. 2006; 82(3): 199-202

4. Dube A, et al. "Modulation of macrophage structure and function by low level He-Ne laser irradiation". Photochem Photobiol Sci. 2003; 2(8): 851-5

5. Hemvani N, et al. "He-Ne and nitrogen laser irradiation accelerates the phagocytic activity of human monocytes". Photomed Laser Surg. 2005; 23(6): 571-4

6. Al-Ayami M, et al. "Low level laser treatment of primary and secondary Raynaud's phenomenon". Vasa. 2001; 30(4): 581-4

7. Schindl A, et al. "Systemic effects of low intensity laser irradiation on skin microcirculation in patients with diabetic microangiopathy". Microvasc. Res. 2002; 64(2): 240-6

8. Velizhanina IA, et al. "Efficacy of low intensity laser radiation on essential hypertension". Klin Med (Mosk) 2001; 79(1): 41-44

9. Nikitin AV, et al. "Efficacy of noninvasive hemolaserotherapy in patients with bronchial asthma and concomitant rhinosinusitis". Ter Arkh. 2004; 76(3):20-3

10. Siposan DG, et al. "Relative variation to received dose of some erythrocytic and leukocytic indices of human blood as a result of low-level laser radiation: an in vitro study". J Clin Laser Med Surg. 2001; 19(2):89-103

11. Khotiaintsev KS, et al. "Laser blood irradiation effect on electrophysiological characteristics of acute coronary syndrome patients". Proc. SPIE Vol. 2929, p. 132-137

12. Shuvalova IN, et al. "The effects of low-intensity laser radiation in the infrared and red ranges on arterial pressure regulation in patients with borderline hypertension". Lik Sprava Oct-Nov;(7):141-3

13. Vitreshchak TV, et al. "Laser modification of the blood in vitro and in vivo in patients with Parkinson's disease". Bull Exp Biol Med. 2003; 135(5):430-2

14. Koultcavenia, EV. "Influence of LLLT on kidney functions". Proc. SPIE Vol. 3569, p. 70-74

15. Kovalyova TV, et al. "Dynamics of lipid metabolism and peripheral blood flow rates in patients with atherosclerosis in conjunction with renal dysfunction after the course of combined laser therapy". RF Russian Medical University, 13th State Clinic hospital, Moscow, RF

16. Vasil'ev AP, et al. "Laser correction of microcirculation disorders in patients having CHD with hypercholesterinemia". Klin Med (Mosk). 2005;83(2):33-7

17. Proc 9th Congress Soc Laser Surgery & Medicine, Anaheim, CA: 26 Nov. 1991

[ home ] [ about us ] [ expertise ] [ projects ] [ demining ] [ financing ] [ manufacturing ]